LERNER LORENA RAQUEL (Chief Scientific Officer) sold 11.5% of their position (3.57K shares) of KEROS THERAPEUTICS, INC. on the open market
Open‑market sale worth $36.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0002081359-26-000008
Officer· Chief Scientific Officer
Since Feb 2026
-3.57K
Net shares
Net seller
$36.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.57K
Price / share
$10.29
Trade value
$36.71K
% of position
11.5%
8/18/2026
31.13K→27.56K
Total
Net shares
−3.57K
Net value
-$36.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −3.57K | $10.29 | $36.71K | 11.5% | 31.13K | 27.56K |
| Total | −3.57K | -$36.71K | ||||||
Derivative Transactions0
No derivative transactions reported